German court overturns Glaxo’s patent on Advair
A German court ruled a key patent on GlaxoSmithKline Plc’s lung drug Advair is not valid, dealing a blow to the top-selling lung drug in Europe’s biggest market. Glaxo said on Thursday it would consider an appeal to a higher court, adding there were still obstacles to generic companies launching cheaper copies of the inhaled […]